Bone Marrow Transplantation - Table of Contents alert Volume 51 Issue 12

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 51, Issue 12 (December 2016) In this issue Review Original Articles Letters to the Editor Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Marking 30 years of BMT publishing excellence - 1986 to 2016  Springer Nature is pleased to mark 30 years of Bone Marrow Transplantation journal publishing. We are commemorating the anniversary by giving everyone access to the 10 most cited BMT articles of all time and publishing an editorial by original editor Robert Gale that looks back over the journal's history.     Review Top Striving to cure adult T-cell leukaemia/lymphoma: a role for allogeneic stem cell transplant? E H Phillips, A Hodson, O Hermine, A Bazarbachi and K Cwynarski Bone Marrow Transplant 2016 51: 1549-1555; advance online publication, September 12, 2016; 10.1038/bmt.2016.154 Abstract | Full Text Original Articles Top ACUTE LEUKEMIA YKL-40 in allogeneic hematopoietic cell transplantation after AML and myelodysplastic syndrome B Kornblit, T Wang, S J Lee, S R Spellman, X Zhu, K Fleischhauer, C Müller, M R Verneris, K Müller, J S Johansen, L Vindelov and P Garred Bone Marrow Transplant 2016 51: 1556-1560; advance online publication, July 18, 2016; 10.1038/bmt.2016.192 Abstract | Full Text Post-transplant high-dose cyclophosphamide after HLA-matched vs haploidentical hematopoietic cell transplantation for AML A Rashidi, M Slade, J F DiPersio, P Westervelt, R Vij and R Romee Bone Marrow Transplant 2016 51: 1561-1564; advance online publication, August 15, 2016; 10.1038/bmt.2016.217 Abstract | Full Text PLASMA CELL DISORDERS Role of MRD status in relation to clinical outcomes in newly diagnosed multiple myeloma patients: a meta-analysis O Landgren, S Devlin, M Boulad and S Mailankody Bone Marrow Transplant 2016 51: 1565-1568; advance online publication, September 5, 2016; 10.1038/bmt.2016.222 Abstract | Full Text Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994–2009 S Rosengren, U-H Mellqvist, H Nahi, K Forsberg, S Lenhoff, O Strömberg, L Ahlberg, O Linder and K Carlson Bone Marrow Transplant 2016 51: 1569-1572; advance online publication, October 3, 2016; 10.1038/bmt.2016.249 Abstract | Full Text APLASTIC ANEMIA Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD? S Gallo, A E Woolfrey, L M Burroughs, B E Storer, M E D Flowers, P Hari, M A Pulsipher, S Heimfeld, H-P Kiem, B M Sandmaier and R Storb Bone Marrow Transplant 2016 51: 1573-1578; advance online publication, August 1, 2016; 10.1038/bmt.2016.198 Abstract | Full Text TRANSPLANT TOXICITIES Autoimmune hemolysis and immune thrombocytopenic purpura after cord blood transplantation may be life-threatening and warrants early therapy with rituximab V Bhatt, L Shune, E Lauer, M Lubin, S M Devlin, A Scaradavou, R Parameswaran, M A Perales, D M Ponce, S Mantha, N A Kernan and J N Barker Bone Marrow Transplant 2016 51: 1579-1583; advance online publication, September 19, 2016; 10.1038/bmt.2016.228 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE Ruxolitinib treatment for GvHD in patients with myelofibrosis Y Mori, K Ikeda, T Inomata, G Yoshimoto, N Fujii, H Ago and T Teshima Bone Marrow Transplant 2016 51: 1584-1587; advance online publication, October 10, 2016; 10.1038/bmt.2016.256 Abstract | Full Text Chronic graft versus host disease burden and late transplant complications are lower following adult double cord blood versus matched unrelated donor peripheral blood transplantation J A Gutman, K Ross, C Smith, H Myint, C-K Lee, R Salit, F Milano, C Delaney, D Gao and D A Pollyea Bone Marrow Transplant 2016 51: 1588-1593; advance online publication, July 11, 2016; 10.1038/bmt.2016.186 Abstract | Full Text QOL AND PATIENTS' CARE Pre-transplant emotional support is associated with longer survival after allogeneic hematopoietic stem cell transplantation K B Ehrlich, G E Miller, T Scheide, S Baveja, R Weiland, J Galvin, J Mehta and F J Penedo Bone Marrow Transplant 2016 51: 1594-1598; advance online publication, July 18, 2016; 10.1038/bmt.2016.191 Abstract | Full Text Letters to the Editor Top Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis P V O'Donnell, M Eapen, M M Horowitz, B R Logan, A DiGilio, C Brunstein, E J Fuchs, M E D Flowers, R Salit, K Raj, A Pagliuca, K Bradstock, A Granata, L Castagna, S Furst and D Blaise Bone Marrow Transplant 2016 51: 1599-1601; advance online publication, August 15, 2016; 10.1038/bmt.2016.215 Full Text Impact of haploidentical hematopoietic cell transplantation conditioning intensity on the incidence and severity of post-transplantation viral infections R V Raj, P Hari, M Pasquini, N Epperla, A D'Souza, T Fenske, B E Shaw, J D Rizzo, W Drobyski and M Hamadani Bone Marrow Transplant 2016 51: 1602-1604; advance online publication, September 5, 2016; 10.1038/bmt.2016.216 Full Text Hemolytic anemia with null PKLR mutations identified using whole exome sequencing and cured by hematopoietic stem cell transplantation combined with splenectomy M Kim, J Park, J Lee, W Jang, H Chae, H Choi, J Kim, A Kwon, J-W Lee, B Cho, Y Kim and N-G Chung Bone Marrow Transplant 2016 51: 1605-1608; advance online publication, September 5, 2016; 10.1038/bmt.2016.218 Full Text Outcomes of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory HIV-associated lymphoma R Ramaswami, A Dalla Pria, K Parker, S McCann, E J Kanfer, M Nelson and M Bower Bone Marrow Transplant 2016 51: 1609-1611; advance online publication, September 5, 2016; 10.1038/bmt.2016.219 Full Text Variations in practice in UK transplant centers: results of a related donor care survey C Anthias, A Peniket, K Kirkland, J A Madrigal and B E Shaw Bone Marrow Transplant 2016 51: 1612-1614; advance online publication, September 5, 2016; 10.1038/bmt.2016.220 Full Text Improved reproducibility and quality of GvHD biomarker assay: application of multiplex microfluidic channel system P Anandi, X Tian, F Chinian, C R Cantilena, N Dunavin, N Hensel, D Draper, E Koklanaris, S Maxwell, J Superata, P Muranski, M Battiwalla, S Paczesny, A J Barrett and S Ito Bone Marrow Transplant 2016 51: 1615-1616; advance online publication, September 5, 2016; 10.1038/bmt.2016.226 Full Text Minimal detectable disease confirmed by flow cytometry and poor outcome after autologous stem cell transplantation in peripheral T-Cell lymphomas J Gauthier, L Holmberg, D Wu, W Bensinger, A K Gopal, O Press, D Maloney, D J Green, B G Till, D Byelykh and A Shustov Bone Marrow Transplant 2016 51: 1617-1619; advance online publication, October 24, 2016; 10.1038/bmt.2016.227 Full Text Rapid identification of cytokine release syndrome after haploidentical PBSC transplantation and successful therapy with tocilizumab C Cho and M A Perales Bone Marrow Transplant 2016 51: 1620-1621; advance online publication, September 26, 2016; 10.1038/bmt.2016.229 Full Text Toxoplasmosis encephalitis with immune-reconstitution inflammatory syndrome in an allogeneic stem cell transplant patient: a case report M E Gatti-Mays, M Manion, L N Bowen, G T Brown, R L Danner, O Khan, A Nath, M Battiwalla, A J Barrett and S Ito Bone Marrow Transplant 2016 51: 1622-1624; advance online publication, September 19, 2016; 10.1038/bmt.2016.230 Full Text Risk factors of clinically refractory CMV reactivation following allogeneic HSCT: a single-center study in China X Bao, Q Zhu, S Xue, Y Xu, X Ma, F Chen, X Hu, Z Zhu, S Chen, A Sun, D Wu, Y Song and H Qiu Bone Marrow Transplant 2016 51: 1625-1627; advance online publication, October 17, 2016; 10.1038/bmt.2016.231 Full Text Peripheral blood versus bone marrow transplant in patients with aplastic anemia, an unresolved issue A Ghavamzadeh, K Alimoghaddam, M Jalili, S A Mousavi, B Bahar, A Kasaeian, A A Hamidieh, M Behfar, M Vaezi, A Jalali and M Jahani Bone Marrow Transplant 2016 51: 1628-1630; advance online publication, September 26, 2016; 10.1038/bmt.2016.235 Full Text Assessing pilot vial material as a surrogate for functional and phenotypic stem cell markers in cryopreserved haematopoietic stem cell product L Bai, L Peters, W Xia, G Best, K Wong, C Ward and M Greenwood Bone Marrow Transplant 2016 51: 1631-1632; advance online publication, September 26, 2016; 10.1038/bmt.2016.236 Full Text Diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome of the liver: problems of interpretation L Volin, R Niittyvuopio, J Heiskanen, V Lindström, A Nihtinen, L Sahlstedt and T Ruutu Bone Marrow Transplant 2016 51: 1633-1635; advance online publication, September 26, 2016; 10.1038/bmt.2016.237 Full Text High-dose cytarabine added to CY/TBI improves the prognosis of cord blood transplantation for acute lymphoblastic leukemia in adults: a retrospective cohort study Y Arai, T Kondo, A Shigematsu, J Tanaka, S Takahashi, T Kobayashi, N Uchida, Y Onishi, J Ishikawa, H Kanamori, M Sawa, A Yokota, Y Kouzai, M Takanashi, T Ichinohe, Y Atsuta and S Mizuta on behalf of the Japan Society for Hematopoietic Cell Transplantation Bone Marrow Transplant 2016 51: 1636-1639; advance online publication, September 19, 2016; 10.1038/bmt.2016.242 Full Text Return to normal life after hematopoietic stem cell transplantation for thalassemia: a study of patients transplanted from matched sibling donors G Caocci, A Vacca, E Piras, V Serreli, C Dessi, M Marcias, P Risso and G La Nasa Bone Marrow Transplant 2016 51: 1640-1641; advance online publication, September 19, 2016; 10.1038/bmt.2016.243 Full Text GvHD-free, relapse-free survival after reduced-intensity allogeneic hematopoietic cell transplantation in older patients with myeloid malignancies A Nazha, L Rybicki, D Abounader, B Bolwell, R Dean, A T Gerds, D Jagadeesh, B K Hamilton, B T Hill, M Kalaycio, H Liu, B Pohlman, R Sobecks, M A Sekeres and N S Majhail Bone Marrow Transplant 2016 51: 1642-1643; advance online publication, October 10, 2016; 10.1038/bmt.2016.254 Full Text Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantation L Castagna, B Sarina, R Crocchiolo, S Bramanti, S Furst, R Devillier, D Coso, R Bouabdallah, D Mokart, L Morabito, S Harbi, L Giordano, A Rimondo, P Jean Weiller, C Carlo-Stella, A Santoro, C Chabannon and D Blaise Bone Marrow Transplant 2016 51: 1644-1646; advance online publication, October 17, 2016; 10.1038/bmt.2016.257 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.